BriaCell Therapeutics Corp. Warrant expiring 2030 (BCTXZ) Live Share Price, Invest From India

BriaCell Therapeutics Corp. Warrant expiring 2030 Stock Performance

as on September 9, 2026 at 4:54 am IST

Day's High
$0.15
Day's Price Range
$0.16
$0.15
6.67%
Upside
52 Week's Low
52 Week's High
$0.06
52-Week Price Range
$0.52
$0.15
63.27%
Downside
246.67%
Upside

BriaCell Therapeutics Corp. Warrant expiring 2030 share price movements today

Previous Close: $0.18
Open: $0.16
Volume: 8.3K
Day's Low - High: $0.15 - $0.16
52 Week Low - High: $0.06 - $0.52

BriaCell Therapeutics Corp. Warrant expiring 2030 Historical Returns

1 Month Return: + 108.01 %
3 Month Return: + 133.75 %
1 Year Return: + 3.89 %
3 Year Return: 0 %
5 Year Return: 0 %

BriaCell Therapeutics Corp. Warrant expiring 2030 Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics Corp. Warrant expiring 2030 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-175.26%

BriaCell Therapeutics Corp. Warrant expiring 2030 vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics Corp. Warrant expiring 2030 with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BriaCell Therapeutics Corp. Warrant expiring 2030	NA	$-	NA	NA	0.00%	NA
Insmed	BUY	$27.6B	348.79%	NA	-76.94%	NA
Alnylam Pharma	BUY	$35.6B	41.34%	46.28	16.13%	NA
Vertex Pharmaceuticals	BUY	$138.4B	184.14%	31.53	86.04%	NA
Regeneron	BUY	$85.2B	23.76%	19.76	84.86%	0.44999999999999996%

Stock Returns calculator for BriaCell Therapeutics Corp. Warrant expiring 2030 Stock including INR - Dollar returns

The BriaCell Therapeutics Corp. Warrant expiring 2030 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BriaCell Therapeutics Corp. Warrant expiring 2030 investment value today

Current value as on today

₹89,809

Returns

-₹10,191

(-10.19%)

Returns from BriaCell Therapeutics Corp. Warrant expiring 2030 Stock

-₹16,667 (-16.67%)

Dollar Impact

₹6,476 (+6.48%)

Indian Investors' Interest in BriaCell Therapeutics Corp. Warrant expiring 2030 Stock

Search interest for BriaCell Therapeutics Corp. Warrant expiring 2030 Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 9, 2026 to September 8, 2026

Change:-36% versus previous 30 day period

BriaCell Therapeutics Corp. Warrant expiring 2030 Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Oct 2025	Jan 2026	Apr 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	0	0	-
Operating Income	-9	-9	-5	-5	-7	-6	-8	-7	-7
EBITDA	-9	-9	-5	-5	-7	-6	-8	-7	-7
Interest Expense	-	-	-	-	-	0	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	1	-1	-5	-6	-6	-8	-7	-7
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-11	1	-1	-5	-6	-6	-8	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Corp. Warrant expiring 2030 Annual Profit & Loss

All numbers in Millions USD

	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Total Revenue	-	-	-	-
Gross Profit	0	0	0	0
Operating Income	-7	-15	-23	-33
EBITDA	-7	-26	-23	-4
Interest Expense	0	0	-	-
Depreciation	0	0	0	0
Income Before Tax	-13	-26	-20	-4
Income Tax Expense	6	0	0	-
Net Income	-13	-26	-20	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Corp. Warrant expiring 2030 Quarterly Cash Flow

All numbers in Millions USD

	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Net Income	1	-1	-5	-6	-6	-8	-8	-7	-7
Operating Cash Flow	-4	-4	-6	-5	-7	-8	-7	-7	-7
Investing Cash Flow	0	0	0	0	0	-7	0	7	-16
Financing Cash Flow	-	4	11	5	14	13	-	27	0
Change in Cash	-5	0	4	0	7	-1	-7	27	-22

BriaCell Therapeutics Corp. Warrant expiring 2030 Annual Cash Flow

All numbers in Millions USD

	Jul 2017	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024	Jul 2025
Net Income	-3	-5	-5	-4	-13	-26	-20	-4	-26
Operating Cash Flow	-1	-4	-5	-1	-7	-12	-23	-24	-28
Investing Cash Flow	0	0	1	-	-	-	-	0	-7
Financing Cash Flow	2	5	2	1	64	-3	3	4	46
Change in Cash	1	0	0	0	57	-16	-19	-20	9

Insights on BriaCell Therapeutics Corp. Warrant expiring 2030

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BCTXZ stock has moved down by -26.4%

About BriaCell Therapeutics Corp. Warrant expiring 2030

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Organisation	BriaCell Therapeutics Corp. Warrant expiring 2030
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Industry	Miscellaneous
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of BriaCell Therapeutics Corp. Warrant expiring 2030

Name	Title
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H.	Chief Medical Officer

FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2030 share price today?

BriaCell Therapeutics Corp. Warrant expiring 2030 share price today is $0.15 as on September 8, 2026 at 11:24 pm IST. BriaCell Therapeutics Corp. Warrant expiring 2030 share today touched a day high of $0.16 and a low of $0.15.

What is the 52 week high and 52 week low for BriaCell Therapeutics Corp. Warrant expiring 2030 share?

BriaCell Therapeutics Corp. Warrant expiring 2030 share touched a 52 week high of $0.52 on October 6, 2025 and a 52 week low of $0.06 on March 9, 2026. BriaCell Therapeutics Corp. Warrant expiring 2030 stock price today i.e. September 8, 2026 at 11:24 pm IST is trending at $0.15,which is 71.15% down from its 52 week high and 172.23% up from its 52 week low.

How to invest in BriaCell Therapeutics Corp. Warrant expiring 2030 Stock (BCTXZ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BriaCell Therapeutics Corp. Warrant expiring 2030 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BriaCell Therapeutics Corp. Warrant expiring 2030 Shares that will get you 10.0000 shares as per BriaCell Therapeutics Corp. Warrant expiring 2030 share price of $0.15 per share as on September 8, 2026 at 11:24 pm IST.

What is the minimum amount required to buy BriaCell Therapeutics Corp. Warrant expiring 2030 Stock (BCTXZ) from India?

Indian investors can start investing in BriaCell Therapeutics Corp. Warrant expiring 2030 (BCTXZ) shares with as little as ₹94.8175 or $1 (as of September 8, 2026 at 11:36 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in BriaCell Therapeutics Corp. Warrant expiring 2030 stock (as per the Rupee-Dollar exchange rate as on September 8, 2026 at 11:36 pm IST). Based on BriaCell Therapeutics Corp. Warrant expiring 2030 share’s latest price of $0.15 as on September 8, 2026 at 11:24 pm IST, you will get 66.6667 shares of BriaCell Therapeutics Corp. Warrant expiring 2030. Learn more about fractional shares .